Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
  • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
  • C12M23/00—Constructional details, e.g. recesses, hinges
  • C12M23/02—Form or structure of the vessel

Definitions

• This invention relates to a method for cell growth, and in particular to the growth of cells in a nutrient medium.
• the nutrient medium may be stationary, e.g ? in a dish, in which case it is tiresome, especially on a large scale, to separate the « products of cell growth from the system.
• Cells may also be grown in a fluent medium, e.g. in order to stimulate cell/nutrient contact and in order to facilitate the replacement of nutrient as it becomes exhausted; however, it is usually then necessary to. stir the system, and, stirring involves undesirable mechanical attrition.
• GB-A-1546554 describes maintaining cells, e.g. lymphoblastoid cells, in suspension in a nutrient medium.
• cells e.g. lymphoblastoid cells
• the medium flows upwardly at a uniform rate.
• the medium reaching the top of the channel is passed downwardly, outside the channel, to provide circulatory flow. Accordingly, cells are maintained in suspension by careful choice of oxygen inflow rate.
• Examples of documents in which cells are stirred or otherwise moved in a nutrient medium are WO-A-84/03709, in which there is a circulatory flow and an orthogonal flow component caused by the introduction of oxygen; EP-A-0078061, in which the partial pressure of oxygen is changed during the growth phase (the cells must be non-adhering mammalian cells) ; and WO-A-82/03227, in which laminar flow is maintained in a "movable culture unit".
• EP-A-0050562 states as its object a process according to earlier proposals for cell growth, but in the complete absence of any means of cell immobilisation.
• the disclosure is of circulating a nutrient medium, in sequence, downwardly through two cylindrical vessels, into one of which oxygen and nutrients can be introduced.
• the other is the "culture vessel", which includes towards its lower end means for separation of tissue material, allowing the downward passage of medium for recir ⁇ ulation.
• a method for the growth of cells in a nutrient medium comprises causing the nutrient medium to flow upwardly . with decreasing velocity, substantially without turbulent flow, and allowing cells to grow at an equilibrium level, in the flow.
• the invention is based upon the principle of flotation, so that cells of one type can grow at a given level in a steady flow, according to the upward velocity of the nutrient medium and the opposing force of gravity, but important advantages are associated with this system.
• apparatus can be engineered to provide a wide variation of flow velocities which can allow the simultaneous growth of various cells (which can form different strata, according to their sedimentation velocity, in the apparatus) .
• cells grow very well in such a system, supported only by the medium, and indeed faster than in a stirred system where they are caused to move.
• the cells are constantly provided with fresh medium, e.g. if spent medium removed from the top of the apparatus is regenerated or replaced before being passed back up the apparatus.
• the products of cell growth, metabolism or lysis are passed upwardly through the apparatus and can be separated from the medium in a cell-free environment; the products may be, for example, antibodies, other desirable proteins and also dead matter, e.g. from cell walls.
• Cells may die naturally or may be induced to rupture by the introduction of suitable materials into the flow, e.g. cell wall-destroying -enzymes.
• Figure 1 is an essentially schematic view of apparatus which can be used in the method of the inventlon;
• Figures 2, 3 and 5 are scale diagrams of three further alternative apparatus which can be used in the invention;
• FIGS. 4 and 6 illustrate systems in which the invention can be operated, the latter in the form of a flow diagram
• FIG. 7 is a schematic representation of a unit which can be used as part of the system illustrated in Fig. 6, and in more detail than Fig. 6.
• DETAILED DESCRIPTION OF THE INVENTION Figs. 1 to 5 show a vessel 1 having a section of gradually increasing and then decreasing diameter, the maximum diameter being shown at 2. There is an inlet 3 at the lower end of the vessel and an outlet 4 at the upper end. The outlet 4 can lead, for example, to means for collection and/or regeneration and/or separation.
• Fig. 1 also shows a pump P.
• the pump P causes nutrient medium to flow upwardly through the vessel 1.
• the flow velocity is greatest at the inlet 3 and the outlet 4, and least at the greatest dia eter 2.
• Cellular material which has been introduced into the vessel finds a certain level, and three stratified bands of cells of different densities are shown at 5, 6 and 7. Products of cellular degradation and metabolism are obtained through the outlet, and the design of the apparatus ensures that there is no turbulent flow below 2, i.e. at the levels of the bands at least. No strata can be formed above the greatest diameter 2, where flow accelerates and removes all material from the vessel 1.
• Figs. 2 to 5 Additional features illustrated in Figs. 2 to 5 are arrows indicating the flow of direction of the medium; a reservoir intake point 8 and a medium collection unit 9 (partially illustrated) in Fig. 2; a reservoir 9 including a Marriott tube 10, silicone tubing 11 and a filling bell 12 in Fig. 4; and three sampling tubes 13 in Fig. 5.
• the design of the apparatus illustrated in Fig ' . 4 is adapted to the use of higher flow rates than can be used in other illustrated apparatus, without turbulence. Relatively high flow rates may be useful when, as is the case for lymphoblastoid cells, clumps of cells can form which can be maintained in suspension (obviously relatively nearer the bottom of the vessel than individual cells) .
• Fig. 6 shows a culture vessel 1 with sampling tubes 13. Nutrient medium is passed through the vessel 1 upwardly, in the direction of the arrows, on operation of the pump P. Medium is taken from, and returned to, a sealed mixing reservoir 14, e.g. 1 litre in volume.
• the mixing reservoir 14, schematically represented in Fig. 6, is illustrated in more detail in Fig.
• Stirring can be effected by means of a magnetic stirrer 23 and magnetic follower 24 (shown only in Fig. 7) .
• Fig. 6 also shows a fresh medium reservoir 9, a pH meter/controller 25 and, electrically connected thereto, a pump 26 which introduces fresh medium, when necessary, and removes medium for collection (see also Example 4) .
• the use of apparatus as illustrated in Figs. 6 and 7 allows maximum economy in terms of medium usage, and also the re ⁇ irculation of products of cell metabolism, lysis, etc. which may beneficially aid cell growth.
• Example 1 illustrates the invention.
• An apparatus was constructed in borosilicate glass, with the properties and dimensions shown in Fig * 2.
• the glass was cleaned with chromic acid, and then attached by silicon tubing to a reservoir and filling bell, as shown in Fig. 3.
• the entire apparatus was flushed through with a concentrated solution of citric acid and then with at least 10 changes of double glass-distilled water.
• the entire apparatus was sterilised by autoclaving.
• Growth medium ⁇ RPMI 1640 with 10% selected foetal calf serum was placed in the reservoir, and run through the apparatus.
• the flow rate was controlled by a variable tubing clamp and measured by collecting medium in a measuring cylinder below the filling bell for measured times.
• Cells (see Examples 2 and 3) were introduced into the tubing with an hypodermic needle and syringe. At a flow rate of 0.5 ml/min, the cells formed horizontal bands in the apparatus.
• the entire apparatus was mounted in a frame, and placed in a carbon dioxide incubator at 37 C, pH 100%, 95% carbon dioxide.
• the medium reservoir was replenished with medium as necessary, and the effluent medium was collected in sterile glass containers.
• the medium collected from the filling bell was tested for immunoglobulin and antibody activity.
• the immunoglobulin levels were about 1 to 5 ⁇ g/ml, and antibody activity was detectable by a sensitive enzyme immuno-assay.
• Human lymphoblastoid cells were introduced into apparatus as in Example 1.
• the human lymphoblastoid cells produced antibody against Pseudomonas aeruginosa serotype 11.
• the culture was maintained for 35 days. During this time the number of cells appeared to increase (the bands became denser, and the lowermost aggregate of clumps became larger) .
• the concentration of human immunoglobulin in the collected medium remained at between 1 and 5 jig/ml.
• Hybrid cells derived from the fusion of mouse myeloma NSO and mouse spleen cells producing antibody, were introduced into apparatus as in Example 1. The cells did not aggregate. They formed a band less than one centimetre deep, several centimetres above the bottom of the apparatus.
• the culture was maintained for 28 days. During this time the density of the band varied. The concentration of mouse immunoglobulin in the collected medium remained at between 3 and 5 ⁇ g/ml.
• Example 4 The culture vessel illustrated in Fig. 5 was incorporated into a fluid flow circuit, as illustrated in Fig. 6.
• the culture vessel was constructed from a two litre volumetric flask. Medium was pumped into the culture at a controlled rate using a Watson Marlow pump, type MHRE 200. The medium as pumped from, and then back into, a reservoir, which was a Gallenkamp Culture Vessel Module (catalogue number FBL-195-010D) , with magnetic stirrer (FBL-280) and magnetic follower, rotating at 60 rpm.
• the reservoir was supplied with 10% carbon dioxide in air at 200 ml/min, as illustrated in more detail in Fig. 7.
• the ports in the top plate of the reservoir carried a filtered air outlet, with reflux air condenser, a pH probe attached to a pH meter (FBL-734-010D) , a medium inlet tube, a medium outlet tube, a sampling tube, and a carbon dioxide and air inlet tube.
• All glass tubing was light-wall borosilicate glass, outside diameter 4 mm, wall thickness 0.8 mm.
• All flexible tubing was medical grade silicone rubber, internal diameter 3 mm, outside diameter 6 mm; before use it was boiled in double-distilled water for one hour and stored in distilled water.
• the ,pH meter was modified (by Gallenkamp) to drive a two-channel peristaltic pump for the medium inlet and the medium outlet. As the pH dropped to 7.0, fresh medium was introduced and used medium removed, to restore the pH to 7.3.
• the assembled apparatus and tubing were autoclaved at 100 kPa (15 psi) for 15 minutes.
• the culture vessel was maintained at 37 C and the reservoir was maintained at 4 C.
• the two were connected by coils of borosilicate glass tubing; the temperature of the medium was raised or lowered by passage from one to the other.
• the apparatus and tubing were filled with RPMI1640 medium supplemented with 10% foetal calf serum, L-glutamine and sodium pyruvate, but without antibiotics.
• Hybrid cells derived from the fusion of a mouse myeloma cell with a mouse splenic B lymphocyte, were introduced into the culture vessel. They formed a band, the height of which was dependent on the flow rate of the maxim . During the culture period of 21 days, the concentration of hybrid cells in the band rose from 3 x

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Sustainable Development (AREA)
• Microbiology (AREA)
• Biotechnology (AREA)
• Biomedical Technology (AREA)
• Biochemistry (AREA)
• General Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Genetics & Genomics (AREA)
• Clinical Laboratory Science (AREA)
• Analytical Chemistry (AREA)
• Apparatus Associated With Microorganisms And Enzymes (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=10563683

Family Applications (1)

Country Status (3)

Families Citing this family (9)

Family Cites Families (3)

• 1984
  • 1984-07-10 GB GB848417590A patent/GB8417590D0/en active Pending
• 1985
  • 1985-07-09 EP EP19850903337 patent/EP0190188A1/de not_active Withdrawn
  • 1985-07-09 WO PCT/GB1985/000307 patent/WO1986000636A1/en unknown

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events